GYRE
Gyre Therapeutics Inc
NASDAQ · Biotechnology
$7.88
+0.37 (+4.93%)
Open$7.64
Previous Close$7.51
Day High$7.90
Day Low$7.58
52W High$13.75
52W Low$6.11
Volume—
Avg Volume67.1K
Market Cap716.22M
P/E Ratio107.69
EPS$0.06
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+279.7% upside
Current
$7.88
$7.88
Target
$29.92
$29.92
$20.05
$29.92 avg
$33.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 93.97M | 231.94M | 230.03M |
| Net Income | 10.73M | -34,891,358 | -29,454,556 |
| Profit Margin | 11.4% | -15.0% | -12.8% |
| EBITDA | 20.63M | -32,635,653 | -32,852,234 |
| Free Cash Flow | — | -26,269,864 | -27,800,469 |
| Rev Growth | +143.3% | -3.5% | +14.1% |
| Debt/Equity | — | 0.25 | 0.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |